Rostroventral caudate putamen involvement in ethanol withdrawal is influenced by a chromosome 4 locus.
Physiological dependence and associated withdrawal episodes are thought to constitute a motivational force that sustains alcohol use and abuse and may contribute to relapse in dependent individuals. Although no animal model duplicates alcoholism, models for specific factors, like withdrawal, are useful for identifying potential genetic and neural determinants of liability in humans. Previously, we identified a quantitative trait locus (QTL) and gene (Mpdz, which encodes the multi-PDZ domain protein) on chromosome 4 with a large effect on alcohol withdrawal in mice. Using congenic mice that confirm this QTL and c-Fos expression as a high-resolution marker of neuronal activation, we report that congenic mice show significantly less neuronal activity associated with alcohol withdrawal in the rostroventral caudate putamen (rvCP), but not other parts of the striatum, compared with background strain mice. Moreover, bilateral rvCP lesions significantly increase alcohol withdrawal severity. Using retrograde (fluorogold) and anterograde (Texas Red conjugated dextran amine) tract tracing, we found that ∼25% of c-Fos immunoreactive rvCP neurons project to caudolateral substantia nigra pars reticulata (clSNr), which we previously found is crucially involved in withdrawal following acute and repeated alcohol exposure. Our results expand upon work suggesting that this QTL impacts alcohol withdrawal via basal ganglia circuitry associated with limbic function, and indicate that an rvCP-clSNr projection plays a critical role. Given the growing body of evidence that the syntenic region of human chromosome 9p and human MPDZ gene are associated with alcohol abuse, our results may facilitate research on alcohol dependence and associated withdrawal in clinical populations.
Chen
G
G
Department of Behavioral Neuroscience and Portland Alcohol Research Center, Portland Veterans Affairs Medical Center and Oregon Health & Science University, Portland, OR 97239-3098, USA.
Buck
K J
KJ
D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D002352:Carrier Proteins / Q000235:genetics; D002421:Caudate Nucleus / Q000502:physiology*; D002492:Central Nervous System Depressants / Q000009:adverse effects*; D033481:Chromosomes, Mammalian / Q000235:genetics*; D000431:Ethanol / Q000009:adverse effects*; D007150:Immunohistochemistry; D008565:Membrane Proteins; D051379:Mice; D020297:Mice, Congenic; D008811:Mice, Inbred DBA; D009415:Nerve Net / Q000502:physiology; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis / Q000235:genetics; D011699:Putamen / Q000502:physiology*; D040641:Quantitative Trait Loci; D013238:Stereotaxic Techniques; D013375:Substance Withdrawal Syndrome / Q000235:genetics* / Q000503:physiopathology / Q000523:psychology
D002352:Carrier Proteins; D002492:Central Nervous System Depressants; D008565:Membrane Proteins; C491750:Mpdz protein, mouse; D016760:Proto-Oncogene Proteins c-fos; D000431:Ethanol